Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials
about
Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitusContinuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetesContinuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetesA Review of Insulin-Dosing Formulas for Continuous Subcutaneous Insulin Infusion (CSII) for Adults with Type 1 DiabetesInsulin delivery methods: Past, present and futureAn Overview of Insulin Pumps and Glucose Sensors for the GeneralistThe evidence base for diabetes technology: appropriate and inappropriate meta-analysisContinuous subcutaneous insulin infusion in adult type 1 diabetes mellitus: data from a registry at the University Medical Centre Ljubljana, Slovenia.Sources of evidence for systematic reviews of interventions in diabetes.In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine.SU-8-based immunoisolative microcontainer with nanoslots defined by nanoimprint lithography.Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps.STAR 3 randomized controlled trial to compare sensor-augmented insulin pump therapy with multiple daily injections in the treatment of type 1 diabetes: research design, methods, and baseline characteristics of enrolled subjects.Disinhibited eating and weight-related insulin mismanagement among individuals with type 1 diabetesThe effectiveness and durability of an early insulin pump therapy in children and adolescents with type 1 diabetes mellitusContinuous Subcutaneous Insulin Infusion (CSII) Pumps for Type 1 and Type 2 Adult Diabetic Populations: An Evidence-Based Analysis.Continuous subcutaneous insulin infusion in patients with diabetes mellitus.Insulin pumpsA 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections.Cost-effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review.Temporal trends in the treatment of pediatric type 1 diabetes and impact on acute outcomesDo perceptions of insulin pump usability impact attitudes toward insulin pump therapy? A pilot study of individuals with type 1 and insulin-treated type 2 diabetes.Diabetic management in high risk patients (pregnancy, insulin pumps).A Comparison of Continuous Subcutaneous Insulin Infusion vs. Multiple Daily Insulin Injection in Children with Type I Diabetes in Kuwait: Glycemic Control, Insulin Requirement, and BMI.Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes.Current status and future of implantable insulin pumps for the treatment of diabetes.Insulin detemir: from concept to clinical experience.The selection of children and adolescents for treatment with continuous subcutaneous insulin infusion (CSII).Emerging evidence for the use of insulin pump therapy in infants, toddlers, and preschool-aged children with type 1 diabetes.Cost-effectiveness of continuous subcutaneous insulin infusion (CSII) in children: illusion or delusion?Insulin therapy in pediatric patients with type I diabetes: continuous subcutaneous insulin infusion versus multiple daily injections.Should the amounts of fat and protein be taken into consideration to calculate the lunch prandial insulin bolus? Results from a randomized crossover trialImproving the computational effort of set-inversion-based prandial insulin delivery for its integration in insulin pumps.Diabetes: advances in treatment.Past, present, and future of insulin pump therapy: better shot at diabetes control.Glucose variability assessed by low blood glucose index is predictive of hypoglycemic events in patients with type 1 diabetes switched to pump therapy.Impact of the Type of Continuous Insulin Administration on Metabolism in a Diabetic Rat ModelA review of artificial pancreas technologies with an emphasis on bi-hormonal therapyContinuous subcutaneous insulin infusion versus multiple daily injections.Comparison of a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) in type 1 diabetes: a randomized open parallel multicenter study.
P2860
Q24240609-401CA7DB-BEDC-49A3-9CBE-4B9BED853578Q24244108-0C62E36D-1557-4E90-8681-136DFF755B67Q24246012-C51AF8D9-B380-470E-BEA2-909A5B8BC6E7Q26741647-626C8F33-3514-4C1D-B700-DB0F1D4E4859Q26750895-D20471B0-1F4C-4E84-AE4B-C4455A1A98EEQ28076381-8AC551C9-9325-4110-83A2-9FA5D108D3F1Q30409804-D776C027-A3EB-4DBD-A1E2-0BE97AD90308Q30564482-8D4EBD14-9BCD-4865-ACE9-C8930A6AECFDQ33223698-6B52D0E1-CE7A-4EB9-A6DB-D277A27D50FFQ33321671-5E8B4231-505E-4DF9-93D9-76236C882C2CQ33735336-A876739E-6E2D-4436-AF69-1E2FB4B84476Q33879565-49A55891-BB94-4D14-8DBE-2678D7DDB478Q33904977-F7C62BA4-BA4A-44CD-8F6E-B29775D9A39CQ34034192-AFB99D4A-BA90-425B-9BEE-4E9AC7719829Q34360873-A5540423-3A21-4FCF-9158-CEF38B31C183Q34449270-4515E1CF-C4AB-433E-8864-CC6598BD5FD9Q35199907-318153A2-58D7-40D5-BFEC-3F3E45433595Q35274358-BBE98F86-7F77-4D04-A756-ABF1525F8556Q35336944-A24BFE2D-B9A6-474B-AEEB-FDE800A7ED8AQ35627208-CA145722-C60A-4F7D-B1F3-34D6467109D0Q35762308-D4C8017B-75F8-43EF-BC0A-6380CEF9D605Q35830400-88E2B398-6196-4AC5-B446-D3F88D27B219Q35983217-C7815149-EA2B-40BC-906A-7EB9131FBAF1Q36076863-FDD70C28-8753-40C0-902A-E34302A67E34Q36297813-86DC5AE1-BDD5-47A3-9232-B83815665576Q36314998-DDFA707E-017C-4C2D-870F-1592DEE5E7A4Q36382590-99EA9D48-C6D1-4238-B067-E6F65ED45EF4Q36506891-E9E2D68F-B411-4346-A16E-58E8C244F24AQ36506893-60759C0A-29D0-442A-B14A-FF41248FA6ACQ36506909-ECE86758-A0CC-4D4D-AD23-995615D548F0Q36559053-923590AE-4C23-4CF6-923B-08335AA01281Q36572838-7F285C19-D401-4F9B-8015-65AD0689821EQ36605821-13F3602D-1E63-4CA7-BCA4-724FA579F885Q36834433-B9BA5309-A4E3-43DE-9652-4F5A3C856099Q36924597-DF5B088D-BED5-4A7D-AF91-7DB1FD8CB028Q37022673-CF0D6D8B-176C-47E6-80E8-4D0CA7208D29Q37140805-58ED64AA-9887-4665-9302-55EA58045D32Q37154369-48578379-9CB8-4CCF-9A8E-59DF1CBADB57Q37194898-6A788DFD-FFE5-4FF4-A9FB-6BB8A2108ECFQ37235857-6B7EF5E5-1E6C-4526-A2BB-5AC050807880
P2860
Glycaemic control with continuous subcutaneous insulin infusion compared with intensive insulin injections in patients with type 1 diabetes: meta-analysis of randomised controlled trials
description
2002 nî lūn-bûn
@nan
2002 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մարտին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Glycaemic control with continu ...... f randomised controlled trials
@ast
Glycaemic control with continu ...... f randomised controlled trials
@en
Glycaemic control with continu ...... f randomised controlled trials
@nl
type
label
Glycaemic control with continu ...... f randomised controlled trials
@ast
Glycaemic control with continu ...... f randomised controlled trials
@en
Glycaemic control with continu ...... f randomised controlled trials
@nl
prefLabel
Glycaemic control with continu ...... f randomised controlled trials
@ast
Glycaemic control with continu ...... f randomised controlled trials
@en
Glycaemic control with continu ...... f randomised controlled trials
@nl
P2093
P2860
P921
P356
P1433
P1476
Glycaemic control with continu ...... f randomised controlled trials
@en
P2093
John Pickup
Martin Mattock
Sally Kerry
P2860
P356
10.1136/BMJ.324.7339.705
P407
P577
2002-03-01T00:00:00Z